Asian Spectator

Inovio Achieves Third Cancer Indication Milestone for MEDI0457...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
PLYMOUTH MEETING, Pennsylvania, Apr. 8, 2019 /PRNewswire-AsiaNet/-- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that it achieved a third indication milestone from AstraZeneca resulting from dosing a patient in a Phase 2 combination trial evaluating MEDI0457 (formerly called INO-3112) in combination ...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Why Now Is the Perfect Time to Lease an Electric Vehicle?

Australia is seeing strong year on year growth of EVs, with government incentives, advancements in technology, and environmental awareness driving more people to consider electric vehicles. If you’ve...

Mengungkap manfaat tak terduga dari menjadi orang pelupa

Jangan putus asa!Asier RomeroLupa adalah bagian dari kehidupan kita sehari-hari. Kamu barangkali pernah masuk ke sebuah ruangan dan lupa alasan mengapa kamu masuk ke sana. Atau mungkin, seseorang meny...

‘Necro-branding’: Bisnis triliunan pernak-pernik mendiang artis

bissig/ShutterstockApakah kamu memiliki pernak-pernik legenda dunia yang sudah lama meninggal seperti Elvis Presley, Putri Diana, David Bowie, Prince, atau Michael Jackson? Ataupun legenda Indonesia s...



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion